In conclusion, the combined treatment of low dose 5-Fu and TRAIL showed significant synergistic effects on human gastric adenocarcinoma AGS cells and may be a promising treatment for gastric cancer. This evidence concerns the gene TNFSF10 and gastric adenocarcinoma.